Skip Nav Destination
Issues
1 February 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Editorial
The Biology Behind
Review
Report from the Food and Drug Administration
Pemetrexed in Malignant Pleural Mesothelioma
Maitreyee Hazarika; Robert M. White, Jr.; Brian P. Booth; Yong-Cheng Wang; Doo Y. Lee Ham; Cheng Yi Liang; Atiqur Rahman; Jogarao V.S. Gobburu; Ning Li; Rajeshwari Sridhara; David E. Morse; Richard Lostritto; Patricia Garvey; John R. Johnson; Richard Pazdur
Human Cancer Biology
Aberrant Expression and Potency as a Cancer Immunotherapy Target of Inhibitor of Apoptosis Protein Family, Livin/ML-IAP in Lung Cancer
Hiroyuki Hariu; Yoshihiko Hirohashi; Toshihiko Torigoe; Hiroko Asanuma; Midori Hariu; Yasuaki Tamura; Katsuyuki Aketa; Chika Nabeta; Katsuya Nakanishi; Kenjiro Kamiguchi; Yoshinori Mano; Hiroshi Kitamura; Junichi Kobayashi; Tomohide Tsukahara; Noriharu Shijubo; Noriyuki Sato
Aberrant Methylation and Silencing of the BNIP3 Gene in Colorectal and Gastric Cancer
Masafumi Murai; Minoru Toyota; Hiromu Suzuki; Ayumi Satoh; Yasushi Sasaki; Kimishige Akino; Masako Ueno; Fumihiko Takahashi; Masanobu Kusano; Hiroaki Mita; Kazuyoshi Yanagihara; Takao Endo; Yuji Hinoda; Takashi Tokino; Kohzoh Imai
Increased Heparanase Expression Is Caused by Promoter Hypomethylation and Up-Regulation of Transcriptional Factor Early Growth Response-1 in Human Prostate Cancer
Tatsuya Ogishima; Hiroaki Shiina; Julia E. Breault; Laura Tabatabai; William W. Bassett; Hideki Enokida; Long-Cheng Li; Toshifumi Kawakami; Shinji Urakami; Leopoldo A. Ribeiro-Filho; Masaharu Terashima; Makoto Fujime; Mikio Igawa; Rajvir Dahiya
Coexpression of Erythropoietin and Erythropoietin Receptor in Von Hippel-Lindau Disease–Associated Renal Cysts and Renal Cell Carcinoma
Youn-Soo Lee; Alexander O. Vortmeyer; Irina A. Lubensky; Timothy W.A. Vogel; Barbara Ikejiri; Sophie Ferlicot; Gérard Benoît; Sophie Giraud; Edward H. Oldfield; W. Marston Linehan; Bin T. Teh; Stéphane Richard; Zhengping Zhuang
Imaging, Diagnosis, Prognosis
Expression of the FOXP1 Transcription Factor Is Strongly Associated with Inferior Survival in Patients with Diffuse Large B-Cell Lymphoma
Alison H. Banham; Joseph M. Connors; Philip J. Brown; Jacqueline L. Cordell; German Ott; Gayatri Sreenivasan; Pedro Farinha; Douglas E. Horsman; Randy D. Gascoyne
A Predictor Based on the Somatic Genomic Changes of the BRCA1/BRCA2 Breast Cancer Tumors Identifies the Non-BRCA1/BRCA2 Tumors with BRCA1 Promoter Hypermethylation
Sara Alvarez; Ramon Diaz-Uriarte; Ana Osorio; Alicia Barroso; Lorenzo Melchor; Maria Fe Paz; Emiliano Honrado; Raquel Rodríguez; Miguel Urioste; Laura Valle; Orland Díez; Juan Cruz Cigudosa; Joaquin Dopazo; Manel Esteller; Javier Benitez
The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non–Small Cell Lung Cancers
Masaki Tokumo; Shinichi Toyooka; Katsuyuki Kiura; Hisayuki Shigematsu; Kunitoshi Tomii; Motoi Aoe; Kouichi Ichimura; Toshihide Tsuda; Masaaki Yano; Kazunori Tsukuda; Masahiro Tabata; Hiroshi Ueoka; Mitsune Tanimoto; Hiroshi Date; Adi F. Gazdar; Nobuyoshi Shimizu
Transcriptional Profiles in Peripheral Blood Mononuclear Cells Prognostic of Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma
Michael E. Burczynski; Natalie C. Twine; Gary Dukart; Bonnie Marshall; Manuel Hidalgo; Walter M. Stadler; Theodore Logan; Janice Dutcher; Gary Hudes; William L. Trepicchio; Andrew Strahs; Fred Immermann; Donna K. Slonim; Andrew J. Dorner
Early Lymphocyte Recovery Predicts Superior Survival after Autologous Hematopoietic Stem Cell Transplantation for Patients with Primary Systemic Amyloidosis
Luis F. Porrata; Morie A. Gertz; Mark R. Litzow; Martha Q. Lacy; Angela Dispenzieri; David J. Inwards; Stephen M. Ansell; Ivanna N.M. Micallef; Dennis A. Gastineau; Michele Elliott; William J. Hogan; Suzanne R. Hayman; Ayalew Tefferi; Svetomir N. Markovic
Cancer Therapy: Clinical
A Phase I Trial and Pharmacokinetic Study of Tipifarnib, a Farnesyltransferase Inhibitor, and Tamoxifen in Metastatic Breast Cancer
Peter F. Lebowitz; Jennifer Eng-Wong; Brigitte C. Widemann; Frank M. Balis; Nalini Jayaprakash; Catherine Chow; Geoff Clark; Susan B. Gantz; David Venzon; JoAnne Zujewski
Cancer Therapy: Preclinical
Antitumor Activity of ZD6474, a Vascular Endothelial Growth Factor-2 and Epidermal Growth Factor Receptor Small Molecule Tyrosine Kinase Inhibitor, in Combination with SC-236, a Cyclooxygenase-2 Inhibitor
Concetta Tuccillo; Marco Romano; Teresa Troiani; Erika Martinelli; Floriana Morgillo; Ferdinando De Vita; Roberto Bianco; Gabriella Fontanini; Raffaele A. Bianco; Giampaolo Tortora; Fortunato Ciardiello
Combination of IFN-α and 5-Fluorouracil Induces Apoptosis through IFN-α/β Receptor in Human Hepatocellular Carcinoma Cells
Motoi Kondo; Hiroaki Nagano; Hiroshi Wada; Bazarragchaa Damdinsuren; Hirofumi Yamamoto; Nobuaki Hiraoka; Hidetoshi Eguchi; Atsushi Miyamoto; Tameyoshi Yamamoto; Hideo Ota; Masato Nakamura; Shigeru Marubashi; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
A Fiber-Modified, Secretory Leukoprotease Inhibitor Promoter-Based Conditionally Replicating Adenovirus for Treatment of Ovarian Cancer
Daniel T. Rein; Martina Breidenbach; Tyler O. Kirby; Tie Han; Gene P. Siegal; Gerd J. Bauerschmitz; Minghui Wang; Dirk M. Nettelbeck; Yuko Tsuruta; Masato Yamamoto; Peter Dall; Akseli Hemminki; David T. Curiel
Cancer Prevention
Letters to the Editor
Corrections
Advertisement